FALCO HOLDINGS Co., Ltd. (4671.T)
JPY 2314.0
(0.56%)
JPY 2314.0
(0.56%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 43 Billion JPY | -8.33% |
| 2022 | 46.91 Billion JPY | -6.19% |
| 2021 | 50 Billion JPY | 14.67% |
| 2020 | 43.6 Billion JPY | 0.98% |
| 2019 | 43.18 Billion JPY | -2.2% |
| 2018 | 44.15 Billion JPY | -3.93% |
| 2017 | 45.96 Billion JPY | -0.02% |
| 2016 | 45.97 Billion JPY | -5.66% |
| 2015 | 48.72 Billion JPY | 4.58% |
| 2014 | 46.59 Billion JPY | -20.22% |
| 2013 | 58.4 Billion JPY | -6.94% |
| 2012 | 62.75 Billion JPY | 3.17% |
| 2011 | 60.82 Billion JPY | 6.67% |
| 2010 | 57.02 Billion JPY | 0.0% |
| 2009 | - JPY | -100.0% |
| 2008 | 37.46 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 10.72 Billion JPY | 0.25% |
| 2023 Q4 | 10.69 Billion JPY | -2.69% |
| 2023 Q3 | 10.98 Billion JPY | 2.83% |
| 2023 Q2 | 10.68 Billion JPY | 0.46% |
| 2023 Q1 | 10.63 Billion JPY | -3.6% |
| 2023 FY | 43 Billion JPY | -8.33% |
| 2022 FY | 46.91 Billion JPY | -6.19% |
| 2022 Q3 | 11.72 Billion JPY | -6.82% |
| 2022 Q1 | 11.56 Billion JPY | -14.74% |
| 2022 Q2 | 12.58 Billion JPY | 8.81% |
| 2022 Q4 | 11.03 Billion JPY | -5.9% |
| 2021 Q3 | 11.74 Billion JPY | -7.29% |
| 2021 Q1 | 12.02 Billion JPY | 3.1% |
| 2021 FY | 50 Billion JPY | 14.67% |
| 2021 Q2 | 12.67 Billion JPY | 5.42% |
| 2021 Q4 | 13.56 Billion JPY | 15.47% |
| 2020 Q3 | 11.55 Billion JPY | 8.63% |
| 2020 Q2 | 10.64 Billion JPY | 9.12% |
| 2020 Q4 | 11.65 Billion JPY | 0.87% |
| 2020 FY | 43.6 Billion JPY | 0.98% |
| 2020 Q1 | 9.75 Billion JPY | -6.22% |
| 2019 Q3 | 10.85 Billion JPY | -1.52% |
| 2019 Q1 | 10.91 Billion JPY | 2.75% |
| 2019 FY | 43.18 Billion JPY | -2.2% |
| 2019 Q4 | 10.39 Billion JPY | -4.2% |
| 2019 Q2 | 11.02 Billion JPY | 1.02% |
| 2018 Q3 | 11.45 Billion JPY | 6.4% |
| 2018 FY | 44.15 Billion JPY | -3.93% |
| 2018 Q4 | 10.61 Billion JPY | -7.3% |
| 2018 Q2 | 10.76 Billion JPY | -4.86% |
| 2018 Q1 | 11.31 Billion JPY | -0.54% |
| 2017 Q4 | 11.37 Billion JPY | -2.33% |
| 2017 Q1 | 11.6 Billion JPY | 3.37% |
| 2017 Q3 | 11.65 Billion JPY | 2.83% |
| 2017 Q2 | 11.32 Billion JPY | -2.38% |
| 2017 FY | 45.96 Billion JPY | -0.02% |
| 2016 Q4 | 11.22 Billion JPY | -2.41% |
| 2016 Q2 | 11.47 Billion JPY | -2.55% |
| 2016 Q3 | 11.5 Billion JPY | 0.3% |
| 2016 Q1 | 11.77 Billion JPY | -4.16% |
| 2016 FY | 45.97 Billion JPY | -5.66% |
| 2015 Q1 | 12.17 Billion JPY | 4.18% |
| 2015 Q3 | 12.43 Billion JPY | 5.12% |
| 2015 Q2 | 11.83 Billion JPY | -2.8% |
| 2015 FY | 48.72 Billion JPY | 4.58% |
| 2015 Q4 | 12.28 Billion JPY | -1.27% |
| 2014 Q3 | 11.71 Billion JPY | 2.01% |
| 2014 Q4 | 11.68 Billion JPY | -0.27% |
| 2014 FY | 46.59 Billion JPY | -20.22% |
| 2014 Q1 | 11.7 Billion JPY | 3.06% |
| 2014 Q2 | 11.48 Billion JPY | -1.84% |
| 2013 Q2 | 15.49 Billion JPY | -2.16% |
| 2013 FY | 58.4 Billion JPY | -6.94% |
| 2013 Q1 | 15.84 Billion JPY | -3.71% |
| 2013 Q3 | 15.7 Billion JPY | 1.34% |
| 2013 Q4 | 11.35 Billion JPY | -27.7% |
| 2012 Q3 | 15.38 Billion JPY | 0.03% |
| 2012 FY | 62.75 Billion JPY | 3.17% |
| 2012 Q2 | 15.37 Billion JPY | -1.08% |
| 2012 Q1 | 15.54 Billion JPY | 7.83% |
| 2012 Q4 | 16.45 Billion JPY | 6.94% |
| 2011 FY | 60.82 Billion JPY | 6.67% |
| 2011 Q2 | 15.63 Billion JPY | 1.18% |
| 2011 Q4 | 14.41 Billion JPY | -5.97% |
| 2011 Q3 | 15.33 Billion JPY | -1.9% |
| 2011 Q1 | 15.44 Billion JPY | 13.21% |
| 2010 FY | 57.02 Billion JPY | 0.0% |
| 2010 Q3 | 14.39 Billion JPY | -1.43% |
| 2010 Q2 | 14.6 Billion JPY | 1.59% |
| 2010 Q1 | 14.37 Billion JPY | 0.0% |
| 2010 Q4 | 13.64 Billion JPY | -5.22% |
| 2009 Q3 | 9.75 Billion JPY | 0.0% |
| 2009 FY | - JPY | -100.0% |
| 2009 Q4 | - JPY | -100.0% |
| 2008 Q3 | 9.84 Billion JPY | 0.0% |
| 2008 Q4 | 9.12 Billion JPY | -7.24% |
| 2008 FY | 37.46 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Shin Nippon Biomedical Laboratories, Ltd. | 26.45 Billion JPY | -62.594% |
| DNA Chip Research Inc. | 490.46 Million JPY | -8668.671% |
| Cosmo Bio Company,Limited | 9.34 Billion JPY | -360.46% |
| H.U. Group Holdings, Inc. | 236.95 Billion JPY | 81.85% |
| BML, Inc. | 137.96 Billion JPY | 68.827% |
| Human Metabolome Technologies, Inc. | 1.34 Billion JPY | -3095.952% |
| Precision System Science Co., Ltd. | 3.97 Billion JPY | -980.59% |